source Post navigation Bio-Path's Breakthrough Drug Shows Promise in Diabetes Treatment, Phase 1 Trial Set for 2025 – StockTitan Researchers investigate oxygen's effect on overactive cells in type 2 diabetes – News-Medical.Net